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Anti-signal recognition particle antibody (SRP-Ab) is a myositis-
speciﬁc antibody (MSA) that is found in serum of patients with
myositis characterized by a necrotizing myopathy. Because patients
with SRP-Abs have few extra-muscular manifestations,1 the clinical
characteristics of interstitial pneumonia (IP) with SRP-Ab have not
been clariﬁed. Here, we present three cases of IP with SRP-Ab. Case
1: A 51-year-old man with a one-year history of cough and sputum
was referred to our hospital for gradual progression of his symp-
toms. On admission, he did not have muscle pain or proximal mus-
cle weakness. CK was markedly elevated (1160 U/L), and aldolase
(16.2 U/L), KL-6 (1529 U/mL) and SP-D (312.4 ng/mL) were also
elevated. Auto-immune antibodies analyzed were negative. Pulmo-
nary function tests revealed restrictive respiratory dysfunction. HisFig. 1. Chest radiograph on admission. Case 1 (a, b): Consolidation was observed in the bilate
dorsal lung bases. Case 3 (d): Ground-glass opacities were observed in the bilateral lung b
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Bronchoalveolar lavage revealed an increase in lymphocytes. He
was diagnosed as having IP associated with polymyositis (PM).
Although the patient was suspected to have myositis, there was
no evidence of myopathy after careful examination by MRI and
electromyography. Monthly cyclophosphamide pulse therapy was
started. Although CK, aldolase, and ﬁbrotic markers were tempo-
rally normalized, they gradually increased. After six times of cyclo-
phosphamide therapy, oral prednisolone was started. As a result,
muscle enzymes and ﬁbrotic parameters were decreased to normal
levels. His chest radiograph ﬁndings were gradually improved with
signiﬁcant increase in forced vital capacity (FVC) at 46 months after
prednisolone. Positive SRP-Ab was conﬁrmed by RNA immunopre-
cipitation (RIP) assay. Case 2: A 63-year-oldmanwith an 8-year his-
tory of myositis was referred to our hospital for cough and dyspnearal dorsal lower lung ﬁelds. Case 2 (c): Reticular shadows were observed in the bilateral
ases.
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weakness and had been treated with oral prednisolone and cyclo-
phosphamide for ﬁve years. Although muscle strength had been
improved, he developed respiratory symptoms. On admission, he
did not have muscle weakness and cutaneous rash. His CT revealed
reticulation in the bilateral lungs (Fig. 1c). CK (328 U/L), KL-6
(1128 U/mL) and SP-D (361.2 ng/mL) were elevated. Auto-
immune antibodies analyzed were negative. Pulmonary function
tests were within normal range except a low diffusion capacity.
Bronchoalveolar lavage revealed a slight increase in eosinophils.
He was diagnosed as having IP associated with PM, and oral pred-
nisolone and cyclophosphamide were continued. However, due to
the worsening of the patient's dyspnea as well as development of
numbness of the hands and ﬁngers with tapering prednisolone,
intravenous immunoglobulin therapy was conducted. After
improvement of his symptoms, his chest radiological ﬁndings had
not been worsened with oral prednisolone and immunosuppres-
sants. Afterward, although he experienced acute exacerbation of
IP twice, his radiological ﬁndings and symptoms were signiﬁcantly
improved after steroid pulse therapies. Positive SRP-Ab was
conﬁrmed by RIP assay. Case 3: A 54-year-old man with a 6-
month history of progressive upper and lower extremity weakness
was referred to our hospital. He presentedwith a dropped head and
his muscle strength grade was 2/5 in the extremities on admission.
CK (554 U/L) and aldolase (60.2 U/L) were markedly elevated. His
MRI showed profound muscle edema (Fig. 2aec), and myopathic
changes were found on electromyography. A left deltoid muscle bi-
opsy demonstrated degeneration and regeneration muscle ﬁbers
(Fig. 2d, e). His CT revealed ground-glass opacities in the bilateral
lungs (Fig. 1d) and SP-D (182.6 ng/mL) was elevated. Auto-
immune antibodies analyzed were negative. The patient was diag-
nosed as having inﬂammatory myopathy with IP, and oral prednis-
olone was started. His muscle strength was gradually improved,Fig. 2. Axial short tau inversion magnetic resonance images of the shoulders (a), upper (b
semimembranosus and soleus muscles (arrows). Hematoxylineeosin staining of the left del
suggesting macrophage-lineage. No lymphocyte inﬁltration was seen (e). Bar ¼ 200 mm.
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with tapering prednisolone and his muscle strength became
impaired again. On the other hand, no signiﬁcant worsening in
his CT ﬁndings was observed during follow-up. Positive SRP-Ab
was conﬁrmed by RIP assay. Anti-ARS antibody (ARS-Ab) was not
detected in all cases.
The inﬂammatory myopathies are a heterogeneous group char-
acterized by muscle weakness, elevated serum muscle enzymes,
electromyographic abnormalities, and inﬂammation in skeletal
muscle. MSAs, including ARS-Ab and SRP-Ab, are frequently
detected in serum of patients with idiopathic inﬂammatory myop-
athies (IIM) such as PM and dermatomyositis (DM). Although the
etiology of IIM has not been fully clariﬁed, the clinical characteris-
tics of patients with IIM are closely related to the type of MSA.2
SRP, which consists of 7S RNA and six proteins, plays an important
role on proper localization of proteins by regulating protein trans-
location across the endoplasmic reticulum membrane. Inside the
endoplasmic reticulum, SRP recognizes secretary proteins which
are synthesized by ribosomes. The proteins are delivered to the
endoplasmic reticulum membrane and transported across the
membrane.3 SRP-Ab was ﬁrst reported as the antibody found in
a typical PM patient,4 and is found in the serum of ~10% of PM/
DM patients. On the other hand, myopathy with SRP-Ab has
recently been considered to be distinct from other types of inﬂam-
matory myopathies, because muscle weakness was prominent
with marked CK elevation and histological analysis revealed
necrotizing myopathy without inﬂammatory cell inﬁltration.5 In
our two cases, muscle weakness was not found at the diagnosis
of IP. Although SRP-Ab was originally described to be associated
with inﬂammatory myopathy, Hanaoka et al. showed that 32.1%
of SRP-Ab positive cases (9/28) did not have inﬂammatory myop-
athy,6 suggesting SRP-Ab can be positive in patients without
muscular symptoms. In addition, non immune-mediated) and lower (c) legs showed hyper-intense signals in the infraspinatus, subscapularis,
toid muscle showed necrotizing myopathy (d). Most inﬁltrate cells were CD68 positive,
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teristics7 were reported. These results suggest that clinical charac-
teristics of patients with SRP-Ab might be variable. Although the
antibody is reported to bind to the 54-kDa of the SRP (4), the bio-
logical signiﬁcance of SRP-Ab is not known so far. Further studies
are necessary to clarify the biological signiﬁcance of SRP-Ab in pa-
tients with the antibody.
In patients with SRP-Ab, the frequency of IP has been considered
to be low. However, a relatively high frequency (~20%) of IP has re-
ported, and a recent analysis of 100 patients with SRP-Ab has
shown that IP was present in 13%.1 In these patients, the major
CT ﬁndings are ground glass attenuation which is commonly bilat-
eral and symmetrical with subpleural predominance, irregular
linear, reticular opacities and traction bronchiectasis. There ﬁnd-
ings are consistent with non-speciﬁc interstitial pneumonia
(NSIP) pattern.8 In terms of the pathological ﬁndings of the lungs,
most reports have not been described in detail, Kono et al., reported
a ﬁbrotic NSIP pattern (temporally homogenous alveolitis and
interstitial ﬁbrosis) in the specimen obtained by video-assisted
thoracoscopic lung biopsy.9 Although a precise frequency has not
been determined, the frequency of IP is signiﬁcantly lower in pa-
tients with SRP-Ab than those with ARS-Ab.10 Because most previ-
ous reports have focused on muscle features, the clinical
characteristics of IP were not known in patients with SRP-Ab. Mus-
cle lesions have been demonstrated to be generally resistant to
treatment with corticosteroid and/or immunosuppressants.11 How-
ever, in all of our cases, immunosuppressive therapy was effective
for IP. Although there are few reports on the treatment for IP in
such patients, the improvement of chest radiological ﬁndings after
corticosteroid therapy was reported.9 In their case, high resolution
CT ﬁndings showedNSIP pattern aswell as our three cases, suggest-
ing that NSIP is the major IP pattern and immunosuppressive ther-
apy is effective in IP patients with SRP-Ab as reported in ARS-Ab
positive IP.12
The present cases suggest that SRP-Ab could be positive in IP
patients even without signiﬁcant muscle symptoms, and immu-
nosuppressive therapy might be effective for IP in patients with
SRP-Ab.
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